Literature DB >> 5026009

Serum enzyme levels in patients with myasthenia gravis afte aerobic and ischaemic exercise.

J Kolins, J Gilroy.   

Abstract

This study was designed to test the hypothesis that there is a myopathic component in myasthenia gravis. Serum enzyme analyses and lactate and pyruvate assays were undertaken before and after exercise in order to detect possible leakage from defective muscle membrane. A patient and a control group were exercised under (1) aerobic conditions, (2) ischaemic conditions, and (3) aerobic conditions under the influence of edrophonium chloride. The patient group showed a higher resting level of lactate in the aerobic state than did the controls. In addition, the average change in SGOT values in the patient group after one minute of aerobic exercise under the influence of edrophonium chloride exceeded that of the control group. Both these findings suggest possible leakage of enzyme and metabolite from the myasthenic muscle due to a membrane defect and support the hypothesis that there may be a myopathic component in myasthenia gravis. However, the two groups showed no significant differences in CPK values, which are often elevated in primary muscle diseases.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5026009      PMCID: PMC493962          DOI: 10.1136/jnnp.35.1.34

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  SERUM CREATINE PHOSPHOKINASE (CPK) ACTIVITY IN DISORDERS OF HEART AND SKELETAL MUSCLE.

Authors:  J W HESS; R P MACDONALD; R J FREDERICK; R N JONES; J NEELY; D GROSS
Journal:  Ann Intern Med       Date:  1964-12       Impact factor: 25.391

2.  The clinical significance of serum aldolase.

Authors:  J A SIBLEY; G A FLEISHER
Journal:  Proc Staff Meet Mayo Clin       Date:  1954-11-10

3.  Phosphorylase activity and glycogen, glucose-6-phosphate, and lactic acid content of human skeletal muscle in various myopathies.

Authors:  J W Hess
Journal:  J Lab Clin Med       Date:  1965-09

4.  Serum autoantibodies in myasthenia gravis and thymoma: selective affinity for I-bands of striated muscle as a guide to identification of antigen(s).

Authors:  A J Strauss; P G Kemp
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

5.  Does myasthenic serum bind to the neuromuscular junction?

Authors:  D E McFarlin; W K Engel; A J Strauss
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

6.  Pyruvic and lactic acid metabolism in muscular dystrophy, neuropathies and other neuromuscular disorders.

Authors:  I Goto; H A Peters; H H Reese
Journal:  Am J Med Sci       Date:  1967-04       Impact factor: 2.378

7.  Auto-immune aspects of myasthenia gravis.

Authors:  J M Downes; B M Greenwood; S H Wray
Journal:  Q J Med       Date:  1966-01

8.  Myasthenia gravis: effect of the serum and serum globulin on neuromuscular transmission.

Authors:  T Namba; D Grob
Journal:  Neurology       Date:  1968-03       Impact factor: 9.910

Review 9.  Myasthenia gravis as an autoimmune disease: clinical aspects.

Authors:  J A Simpson
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

10.  Autoimmunity: theoretical aspects.

Authors:  W Dameshek
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

View more
  1 in total

1.  Metabolomic profile overlap in prototypical autoimmune humoral disease: a comparison of myasthenia gravis and rheumatoid arthritis.

Authors:  Derrick Blackmore; Liang Li; Nan Wang; Walter Maksymowych; Elaine Yacyshyn; Zaeem A Siddiqi
Journal:  Metabolomics       Date:  2020-01-04       Impact factor: 4.290

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.